Clinical Trials Directory

Trials / Unknown

UnknownNCT04223076

Clinical Effect of Chlorhexidine Mouthwash After Periodontal Surgery

Clinical Performance of Two 0.2% Chlorhexidine Mouth Rinses After Periodontal Surgery. A Blinded, Intra-individual Cross-over Clinical Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
31 (estimated)
Sponsor
University of Oslo · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Chlorhexidine is the gold standard of dental plaque prevention. Recent research have demonstrated that 0.2% Chlorhexidine solutions are more effective than 0.12% and 0.06% Chlorhexidine solutions. Several 0.2% solutions are available on the market. This study aimed to compare effectiveness of two commercially available 0.2% chlorhexidine mouthwashes. Patients, that after initial periodontal therapy, had a need for two periodontal surgeries, will be invited to join. After one surgical session, the patient will receive one 0.2% chlorhexidine solution, and after the next surgical session the patient will receive the other 0.2% chlorhexidine solution. Plaque and gingivitis will be recorded, as well as side effects.

Conditions

Interventions

TypeNameDescription
DRUGChlorhexidine 0.2%, CorsodylComparison of Corsodyl and Curasept
DRUGChlorhexidine 0.2%, CuraseptChlorhexidine 0.2% mouthwash with an Anti Discoloring System (ADS)

Timeline

Start date
2019-03-20
Primary completion
2019-12-20
Completion
2020-12-30
First posted
2020-01-10
Last updated
2020-01-13

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04223076. Inclusion in this directory is not an endorsement.